Peer review reports
From: NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
Original Submission | ||
---|---|---|
14 Oct 2016 | Submitted | Original manuscript |
25 Oct 2016 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 2 | ||
25 Oct 2016 | Submitted | Manuscript version 2 |
24 Nov 2016 | Reviewed | Reviewer Report - Li Che |
2 Dec 2016 | Reviewed | Reviewer Report - Junfang Ji |
26 Dec 2016 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 3 | ||
26 Dec 2016 | Submitted | Manuscript version 3 |
1 Jun 2017 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 4 | ||
1 Jun 2017 | Submitted | Manuscript version 4 |
19 Jun 2017 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 5 | ||
19 Jun 2017 | Submitted | Manuscript version 5 |
25 Jul 2017 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 6 | ||
25 Jul 2017 | Submitted | Manuscript version 6 |
5 Aug 2017 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 7 | ||
5 Aug 2017 | Submitted | Manuscript version 7 |
17 Aug 2017 | Author responded | Author comments - Qijiong Li |
Resubmission - Version 8 | ||
17 Aug 2017 | Submitted | Manuscript version 8 |
Publishing | ||
21 Aug 2017 | Editorially accepted | |
31 Aug 2017 | Article published | 10.1186/s12885-017-3570-4 |